Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
95,058,715
-
Share change
-
+2,844,506
-
Total reported value
-
$2,147,349,372
-
Put/Call ratio
-
7.8%
-
Price per share
-
$22.59
-
Number of holders
-
160
-
Value change
-
+$59,674,967
-
Number of buys
-
73
-
Number of sells
-
80
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2014
As of 30 Jun 2014,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
160 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
95,058,715 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, Viking Global Investors LP, JENNISON ASSOCIATES LLC, BlackRock Fund Advisors, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Institutional Trust Company, N.A., and FRANKLIN RESOURCES INC.
This page lists
160
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.